Blainey A D, Musk A W, Ryan G, Phillips M J, Buccilli C, Troon S, Kidd G
Respiratory Department, Sir Charles Gairdner Hospital, Nedlands, Western Australia.
Br J Ind Med. 1990 Oct;47(10):692-7. doi: 10.1136/oem.47.10.692.
Seasonal grain workers in Western Australia who develop respiratory symptoms after exposure to grain dust develop concomitant changes in lung function and bronchial responsiveness to methacholine. The mechanisms underlying these changes are not known. A detailed study was undertaken of seasonal grain workers in Western Australia to evaluate the effect of nedocromil sodium (Fisons, United Kingdom) on these changes to see if they could be prevented by this drug. Forty seven subjects participated. Symptoms and forced expiratory volume in one second (FEV1) were recorded before the study and before, during, and after each working shift, and bronchial responsiveness to methacholine was measured at the beginning and end of the study. Twenty three subjects received nedocromil and 22 received a placebo in a double blind design; there was no difference in baseline characteristics between the two groups. At the end of the study, no differences were found between the nedocromil and placebo groups in the prevalence of symptoms or development of new symptoms during the study. The drug had no effect on changes in methacholine PD20 or FEV1. As in previous studies, new symptoms developing during the season were more common in atopic subjects and were associated with a fall in methacholine PD20. It is concluded that nedocromil has no effect on the development of new symptoms in grain workers. The mechanisms underlying these symptoms require further study.
在西澳大利亚,季节性谷物工人在接触谷物粉尘后出现呼吸道症状,同时肺功能和对乙酰甲胆碱的支气管反应性也会发生变化。这些变化背后的机制尚不清楚。对西澳大利亚的季节性谷物工人进行了一项详细研究,以评估奈多罗米钠(英国费森斯公司生产)对这些变化的影响,看这种药物是否能预防这些变化。47名受试者参与了研究。在研究前以及每个工作班次之前、期间和之后记录症状和一秒用力呼气量(FEV1),并在研究开始和结束时测量对乙酰甲胆碱的支气管反应性。23名受试者接受奈多罗米治疗,22名受试者接受安慰剂,采用双盲设计;两组的基线特征没有差异。在研究结束时,奈多罗米组和安慰剂组在症状发生率或研究期间新症状的出现方面没有发现差异。该药物对乙酰甲胆碱PD20或FEV1的变化没有影响。与之前的研究一样,在该季节出现的新症状在特应性受试者中更常见,并且与乙酰甲胆碱PD20的下降有关。结论是奈多罗米对谷物工人新症状的出现没有影响。这些症状背后的机制需要进一步研究。